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ABSTRACT
Vector-based RNA interference (RNAi) has emerged
as a valuable tool for analysis of gene function. We
have developed new RNA polymerase II expression
vectors for RNAi, designated SIBR vectors, based
upon the non-coding RNA BIC. BIC contains the
miR-155 microRNA (miRNA) precursor, and we find
that expression of a short region of the third exon
ofmouseBICissufficienttoproducemiR-155inmam-
maliancells.TheSIBRvectorsuseamodifiedmiR-155
precursor stem–loop and flanking BIC sequences to
express synthetic miRNAs complementary to target
RNAs. Like RNA polymerase III driven short hairpin
RNA vectors, the SIBR vectors efficiently reduce tar-
get mRNA and protein expression. The synthetic
miRNAs can be expressed from an intron, allowing
coexpression of a marker or other protein with the
miRNAs. In addition, intronic expression of a syn-
thetic miRNA from a two intron vector enhances
RNAi. A SIBR vector can express two different
miRNAs from a single transcript for effective inhibi-
tion of two different target mRNAs. Furthermore, at
least eight tandem copies of a synthetic miRNA can
be expressed in a polycistronic transcript to increase
the inhibition of a target RNA. The SIBR vectors are
flexible tools for a variety of RNAi applications.
INTRODUCTION
RNA interference (RNAi) has become a commonly used tool
for the analysis of gene function in animals and plants
[for reviews see (1–3)]. Short-interfering RNAs (siRNAs)
of about 21–23 nt can be produced within a cell by Dicer
processing of double-stranded RNAs or hairpin RNAs.
Alternately, synthetic siRNA duplexes can be introduced
into cells by transfection. In both cases, siRNAs enter the
RNA-induced silencing complex (RISC) and guide cleavage
and degradation of endogenous mRNAs that contain
sequences perfectly or near-perfectly complementary to the
siRNAs. siRNA-mediated recognition of target mRNAs is
highly sequence speciﬁc. Animal cells contain numerous
endogenous  22 nt RNAs known as microRNAs (miRNAs)
(4–6) that also can guide cleavage of RNAs with near-perfect
complementary matching sequences (7–9). In addition,
miRNAs also can cause mRNA degradation and/or transla-
tional inhibition when bound to partially complementary sites
in the 30-untranslated region (30-UTR) of mRNAs (10–14).
Cellular miRNAs are derived by processing from 60 to 70 nt
stem–loop precursors [reviewed in (15)]. However, miRNA
precursors are initially synthesized as part of longer primary
RNA transcripts (pri-miRNAs) (16). Most pri-miRNAs appear
to be synthesized by RNA polymerase II (17,18). The nuclear
endonuclease Drosha cleaves a pri-miRNA to release the
stem–loop miRNA precursor (pre-miRNAs) (19). The stem–
loop miRNA precursor is exported from the nucleus and sub-
sequently processed by Dicer to release the mature miRNA in
the cytoplasm. While Dicer processing produces a short RNA
from each arm/strand of the stem–loop precursor, only one of
these two potential miRNAs stably accumulates in most cases.
A number of miRNAs are present in genomic clusters that
appear to be transcribed as polycistronic pri-miRNAs,
allowing the production of multiple miRNAs from a single
transcription unit (16,20,21). Some miRNA precursors are
located in the introns of protein coding genes and can be
coexpressed with the mature mRNAs from the same genes,
suggesting that miRNA precursors can be excised from introns
without disrupting production of the mRNA (22) (M. Deo,
J.-Y. Yu, K.-H. Chung, M. Tippens, and D. L. Turner,
manuscript submitted).
We and others have developed DNA expression vectors for
RNAi in mammalian cells that express short hairpin RNAs
(shRNAs)under the control ofa RNA polymerase IIIpromoter
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doi:10.1093/nar/gkl143[for reviews see (2,23,24)]. shRNAs resemble the short
stem–loop structure of endogenous miRNA precursors, allow-
ing the shRNAs to enter the miRNA synthetic pathway and
be processed by the Dicer endonuclease into  21 nt siRNAs/
miRNAs. Although shRNA vectors are widely used as tools
for the analysis of gene function, existing shRNA vectors have
some limitations. Only a single shRNA is expressed from each
RNA polymerase III promoter, so the inhibition of multiple
genes requires multiple promoters or vectors (25,26). This
causes a concern that the shRNAs may not always be coex-
pressed at similar levels, even when present on the same plas-
mid. Also, identiﬁcation of cells expressing an introduced
shRNA usually requires coexpression of a marker protein
from a separate RNA polymerase II promoter. In this situation,
the marker may not always be coregulated with the shRNA. In
addition, regulated expression from RNA polymerase III pro-
moters is often more difﬁcult in comparison with RNA poly-
merase II driven promoters. RNAi expression vectors that use
RNA polymerase II could potentially overcome many of these
limitations. Cullen and colleagues described avector forRNAi
in which a synthetic siRNA/miRNA is expressed from a syn-
thetic stem–loop precursor based on the miR-30 miRNA pre-
cursor (27,28). Subsequently, other groups have developed
additional miR-30 based vectors for RNAi (29–32). Davidson
and colleagues also described an RNAi vector in which a
synthetic stem–loop was expressed from a capped and
polyadenylated RNA pol II transcript (33). Recently, a trans-
genic mouse for tissue-speciﬁc RNAi has been generated by
introducing an shRNA into the intron of artiﬁcial non-coding
RNA polymerase II RNA (34).
BIC is an evolutionarily conserved non-coding RNA that
cooperates with c-myc to cause lymphoma in chickens when
either inappropriately activated by insertion of a retrovirus or
ectopically expressed in a retroviral vector (35–37). The stem–
loop precursor for the mouse miR-155 miRNA is located
withinthe thirdexonofthe mouse BICgene (38).The minimal
described oncogenic domain for chicken BIC contains the
miR-155 precursor and some ﬂanking sequences, suggesting
that main function of BIC may be to produce miR-155. The
ability to express functional BIC (and presumably miR-155)
from a heterologous RNA polymerase II promoter in a retro-
viral vector (39) suggested that BIC/miR-155 might be a good
sequence framework for construction of RNA polymerase
II-based RNAi vectors. Here we describe a novel vector sys-
tem for mammalian RNAi based upon BIC and the miR-155
miRNA precursor. These vectors use standard RNA poly-
merase II promoters to express a synthetic miRNA (siRNA)
directed against a target mRNA and provide effective inhibi-
tion in mammalian cells. At least two different synthetic
miRNAs can be expressed from a single transcript without
compromising their processing or inhibitory efﬁcacy, allowing
effective inhibition of two genes using a single vector. Alter-
nately, multiple tandem copies of a miRNA can be expressed
in a single polycistronic transcript for increased inhibition. In
addition, the sequences necessary for producing the synthetic
miRNAs can be located within an intron, allowing coupled
expression of the miRNA and a marker protein from the
same transcript. Interestingly, expression of a synthetic
miRNA from a two intron vector further enhanced RNAi.
The miR-155 based vector system offers a ﬂexible system
for the expression of multiple miRNAs combined with
protein marker expression using a single polycistronic
transcription unit.
MATERIALS AND METHODS
Cell culture and transfection
Mouse P19 cells were cultured as described (40). For
luciferase assays,  7 · 10
4 cells were plated per one well
on a 12-well plate and transfected 24 h later. Transfections
were performed with Lipofectamine 2000 (Invitrogen) as
directed by the manufacturer. The transfection efﬁciency
for P19 cells was  50%. For northern blotting,  1 · 10
5
cells were plated in a 35 mm dish and transfected 24 h
later using FuGene6 (Roche).
Plasmids
Plasmids were constructed using standard molecular biology
techniques. Part of the third BIC exon (99–554 nt, based on
accession AY096003) was ampliﬁed by PCR from mouse
genomic DNA and inserted into the CS2+ vector (41,42).
Deletions were constructed using PCR with appropriate pri-
mers. To construct the SIBR cassette, the miR-155 precursor
stem–loop in BIC 134–283 was replaced with a synthetic
polylinker containing two inverted Bbs1 (New England Bio-
labs) sites. SIBR cassettes targeting various mRNAs were
constructed by ligation of64 ntDNA oligonucleotide duplexes
to Bbs1 cut SIBR vectors (see Figure 2A and Table 1 for
sequences). Constructs were veriﬁed by DNA sequencing.
US2 was constructed by replacing the simian CMV promoter
in CS2+ with the human ubiquitin C (ubC) promoter, ﬁrst ubC
exon (non-coding), and ﬁrst ubC intron from pUB GFP (43)
(gift of T. Matsuda and C. Cepko). US2-Ngn2 contains the
mouse neurogenin2 coding region isolated by PCR (J.-Y. Yu
and D.L. Turner, unpublished data). US2-MT expresses six
multimerized myc-epitope tags, while US2-GFP expresses
enhanced green ﬂuorescent protein (GFP) (Clontech). UI2
is a derivative of US2 that has the SIBR cassette inserted
into a non-conserved region in the ubC intron in US2, as well
asanumberofrestrictionsitechangestofacilitateconstruction
of derivatives. GFP or the puromycin resistance protein is
present in the second exon of UI2-GFP-SIBR and UI2-puro-
SIBR respectively. The UI4-GFP-SIBR vector contains the
ubC promoter, the ﬁrst non-coding ubC exon, and ﬁrst ubC
intron, followed by a short non-coding second exon (derived
fromubCexon2andrabbitglobinexon2sequences),followed
by the second intron from the rabbit globin gene. The third
exon of UI4-GFP-SIBR contains the GFP coding region, while
the SIBR cassette is inserted into the middle of the second
intron, along with ﬂanking restriction sites to facilitate con-
struction of tandem SIBR cassettes (sites are identical to UI2).
The remainder of the vector is identical to UI2-GFP-SIBR.
Vectors with tandem luc-1601 or B-Raf + c-Raf SIBR cas-
settes were constructed by excising a SalI-XbaI ﬂanked SIBR
cassette and inserting it between the XhoI and XbaI sites in the
same vector (see Figure 8A and B for schematic). The same
procedure using the UI2-GFP-SIBR Luc-1601·2 vector was
used to construct the UI2-GFP-SIBR Luc-1601·4 vector and
was repeated with the UI2-GFP-SIBR Luc-1601·4 vector to
construct UI2-GFP-SIBR Luc-1601·8.
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ER -G4A activator vector have been described previously
(25). For the UAS-luc-miR-155as reporter, a sequence com-
plementary to miR-155 was introduced by PCR into the
UAS-luc vector after the stop codon of luciferase gene.
The UAS-luc-Tubb3-UTR reporter was also constructed in
the same way by using PCR primers spanning most of the
30-UTR of Tubb3 (1387–1684 nt from NM023279). The UAS-
luc-ND1-UTR reporter contains the entire mouse NeuroD1
30-UTR (1161–2495 nt from AK005073) (44) inserted into
UAS-luc after the luciferase coding region.
Additional vector information and sequences are available
at http://sitemaker.umich.edu/dlturner.vectors.
Luciferase reporter assays
Luciferase assays were done essentially as described, using an
inducible luciferase target (25), except that the medium was
changed to fresh MEMa medium with 1 mM 4-OH-tamoxifen
(Sigma) 24 h after transfection, and cells were lysed 45–
48 h after transfection. The DNA amounts per one well
of a 12-well plate were as follows: UAS-luc, UAS-luc-
miR-155as, UAS-luc-ND1-30-UTR or UAS-luc-Tubb3-30-
UTR, 80 ng; CS2+cbgal, 50 ng; CS2+G4D-ER -G4A,
100 ng; CS2+SIBR, US2-SIBR, UI2-SIBR or UI4-SIBR exp-
ression vectors, 400 ng. For the experiments in Figures 7 and
9, the expression vectors were 100, 200 or 400 ng, with
US2-MT added to maintain a constant DNA amount per
well (other plasmid amounts as above). Reporter activity
was assayed by using the Dual-Light system (Applied Bio-
systems) and was normalized to b-galactosidase activity to
control for transfection efﬁciency variation among different
wells. All reporter assays shown are based on data averaged
from at least three independent transfections.
Northern blotting
P19 cells were transfectedwith 4mgofCS2+SIBR expression
vectors per 35 m dish and lysed at  24 h after transfection for
total RNA isolation using TRIzol (Invitrogen). RNA was
(15 mg) separated by elecrophoresis on 18% polyacrylamide
denaturing gels, transferred with a GENIE electroblotter (Idea
Scientiﬁc) onto Hybond-N+ membrane (Amersham Pharma-
ciaBiotech), andultraviolet crosslinked. DNAoligonucleotide
probes and RNA oligonucleotide size markers were 50 end
labeled with [a-
32P]ATP using T4 polynucleotide kinase.
Hybridization was performed at 42 C in Church–Gilbert solu-
tion (1 mM EDTA, 0.25 M Na2HPO4, 7% SDS) overnight.
Membranes were washed at 42 C, twice with 2· SSPE/0.1%
SDS and once with 0.5· SSPE/0.1% SDS. Blots were exposed
in the Storage Phosphor Screen (Molecular Dynamics) at
room temperature for 48–72 h. Images were obtained with
IPLab Gel H 1.5 g software (Signal Analytics) from Phospho-
rImager 445 SI (Molecular Dynamics). Blots were stripped
by boiling in 0.1% SDS/0.1· SSC solution for 20 min for
reprobing.
Quantitative RT–PCR
P19 cells were cotransfected with UI2-GFP/puro-SIBR vec-
tors(1.5mg)andUS2-Ngn2orUS2-puro (0.5mg)for2mgtotal
DNA per well of a 6-well dish (Costar). The RNA was col-
lected 24 h after transfection and 12 h of puromycin selection
(14 mg/ml). RNA was puriﬁed using an RNeasy kit (Qiagen)
and treated with DNase I (Epicentre). RNA was reverse tran-
scribed using random 12mer primers. cDNA (50 ng) was used
per PCR. RNA levels were measured by SYBR green incorp-
oration (ABI SYBR Green PCR master mix) using a BioRad
iCycler with MyiQ light module. Primers sequences were
obtained from PrimerBank (45) (PrimerBank IDs: RASSF1
13383929a1, HP1g 6680860a1, NeuroD1 33563268a1,
GAPDH 6679937a1 and HPRT 7305155a1). Changes in
expression levels were calculated by comparison with
serial dilutions of input cDNA for the UI2-puro/GFP-SIBR
Table 1. Sequences and predicted precursor structures for miR-155 and
synthetic miRNAs used in the SIBR vectors
Mouse miR-155
(AY096003)
  …UUAAUGCUAAUUGUGAUAGGGGuuuuggcc 
   ||||||||||:     ||||:||:      u
…acAAUUACGAUUG-UCC-AUCCUCagucaguc
Human miR-155 
(AF402776)
  …UUAAUGCUAAUCGUGAUAGGGGuu-uuugc
   ||||||||||| :|| ||||:||:  ||| c
…acAAUUACGAUUA-UAC-AUCCUCagucaaccu
Chicken miR-155
(AF182318)
  …UUAAUGCUAAUCGUGAUAGGGGuu-uuuac
   |||||||||| |:|| ||||:||: ||:| c
…acAAUUACGAUU-GUAC-AUCCUCaguaagucu
Luc-1601
(U47298)
  …UUUAUGAGGAUCUCUCUGAUUUuuuuggcc 
   |||||||||| |||| |||||||:      u
…acAAAUACUCCU-GAGA-ACUAAAagucaguc 
GAPDH-240
(NM_001001303)
  …UUGAUGACAAGCUUCCCAUUCUuuuuggcc 
   ||||||||||: |||| ||||||:      u
…acAACUACUGUUU-AAGG-UAAGAagucaguc 
GAPDH-528
  …UCAUGGAUGACCUUGGCCAGGGuuuuggcc 
   |||||||||||    ||||||||:      u
…acAGUACCUACUGAA--CGGUCCCagucaguc
HP1γ-664
(AK083957)
  …UAAUUCAAAACCCAAGAUCCAGuuuuggcc 
   ||||||||||||   :|||||||:      u
…acAUUAAGUUUUGGA--UUAGGUCagucaguc
HP1γ-903
  …UAACUGUAAAAUCUCCCCAGCGuuuuggcc 
   |||||||||||:   ||||||||:      u 
…acAUUGACAUUUUGU--GGGUCGCagucaguc 
Rassf1-1346
(BC002173)
  …UAAGAGGGAACCCCAGACUCUAuuuuggcc 
   ||||||||||||   :|||||||:      u
…acAUUCUCCCUUGGC--UUGAGAUagucaguc
Rassf1-1623
  …UAUUCAGCCAAUUCUCUCAGGCuuuuggcc
   |||||||||||: || ||||:||:      u
…acAUAAGUCGGUUG-GA-AGUCUGagucaguc
B-Raf-2023
(M64429)
  …UUACUUUAAUGUCUCACUCAGGuuuuggcc 
   ||||||||||: | | ||||:||:      u
…acAAUGAAAUUAU-G-GCGAGUUCagucaguc
c-Raf-2268
(AB057663)
  …UAUGAAGUUAAGGCCCUGUGAGuuuuggcc 
   |||||||||||:  |||||||||:      u
…acAUACUUCAAUUU--GGACACUCagucaguc
Posh-2852
(AF030131)
  …UAAGCUUUCUCCGUGUCCCGUCuuuuggcc
   ||||||||||| :|| |||||||:      u
…acAUUCGAAAGAG-UAC-GGGCAGagucaguc
ND1-380
(AK005073)
  …UAAUUUAAAACGUUCUAGGCGCuuuuggcc 
   ||||||||||| :|| ||||:||:      u
…acAUUAAAUUUUG-GAG-UCCGUGagucaguc
Tubb3-1512
(AF312873)
  …UUAACCUGGGAGCCCUAAUGAGuuuuggcc
   ||||||||||| |  :|||||||:      u 
…acAAUUGGACCCU-GA-GUUACUCagucaguc
Tubb3-1549
  …ACAGAGCCAAGUGGACUCACAUuuuuggcc
   ||||||||||| :|| |||||||:      u
…acUGUCUCGGUUC-UCU-AGUGUAagucaguc
TheexpectedmaturemiRNA(underlined)anditscomplementareinuppercase,
whiletheloopandtwobase30 overhang(sharedbyallprecursors)areshownin
lower case. Watson–Crick basepairs are indicated by lines; GU basepairs indi-
cated by two dots. The mfold program was used to predict precursor structures
(62).AccessionnumbersfortheBICRNAsandforeachtargetmRNAaregiven
(synthetic miRNAs are named by the position of the first matching base of the
target mRNA).
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RNA samples for each vector/condition, assayed using dupli-
cate or triplicate PCR replicates.
Mapping mRNA cleavage sites
RNA-ligase mediated RACE was used to map the internal
cleavage sites of target mRNAs (GeneRacer, Invitrogen).
Of total RNA isolated for quantitative RT–PCR (qRT–
PCR) (above), 5 mg was ligated to an RNA adaptor oligonu-
cleotide. After ﬁrst strand cDNA synthesis primed with a
gene-speciﬁc primer, ligation products were PCR ampliﬁed
with primers complementary to the GeneRacer RNA adaptor
and the gene-speciﬁc primer. After a second round of PCR
with nested primers, PCR products were gel puriﬁed and
cloned into pCR4-TOPO TA cloning vector for sequencing.
Western blotting
P19 cells were plated to a density of 1.1 · 10
5 cells per 35 mm
dish and transfected  24 h later using FuGene6. Each trans-
fection contained a total of 4 mg DNA: 3.5 mg UI2-puro vector
and 0.5 mg US2-GFP. Puromycin was added (14 mg/ml) 7 h
after transfection to select the transfected cells. The
puromycin-containing medium was removed 17 h later, and
the cells were allowed to recover in MEMa with 2.5% FBS
(Hyclone) and 7.5% CS (Hyclone) for an additional 24 h.
Extracts were prepared in Triton Immunoprecipitation (TI)
buffer (10 mM HEPES, pH 7.4, 150 mM NaCl, 1% Triton
X-100, 2 mM EDTA, 0.1% b-mercaptoethanol, 1% aprotinin,
50 mM NaF, 1 mM phenylmethylsulfonyl ﬂuoride). A
Bradford dye-binding protocol (BioRad) was used to normal-
ize samples with respect to total protein concentration prior
to SDS–PAGE. Primary antibodies for western analyses were
a-B-Raf (Santa Cruz sc-166), a-c-Raf (Upstate 05-739) and
a-Erk (generous gift of Kun-Liang Guan, University of
Michigan). Secondary HRP-antibodies for western analyses
were obtained from BioRad. Western blots were developed
using SuperSignal West Dura or Pico Chemiluminescence
reagents (Pierce). Films (Kodak BioMax MR) were scanned
on an Epson Expression 1680 scanner and captured using
VueScan 8.1.3.
Immunofluorescence and microscopy
For indirect immunoﬂuorescence, cells were ﬁxed 5 days after
transfection and processed as described previously (40). Anti-
bodies used were as follows: rabbit anti-GFP polyclonal anti-
body diluted 1:2000 (Molecular Probes); mouse monoclonal
TuJ1 antibody against neuronal class III b-tubulin diluted
1:2000 (CRP); mouse anti-HP1g monoclonal antibody diluted
1:1500 (Chemicon); goat anti-rabbit Alexa-488 conjugated
secondary antibody and goat anti-mouse Alexa-546 conju-
gated secondary antibody diluted 1:1000 (Molecular Probes).
GFP ﬂuorescence in cells transfected with ubC-driven GFP
vectors was photographed in cells ﬁxed 45–48 h after
transfection, using a Zeiss Axiovert S100 inverted ﬂuores-
cence microscope with a DAGE 330 video camera and ImageJ
software version 1.34. Image brightness was reduced by 20%
and composite images were assembled using Adobe
Photoshop 7.0.
RESULTS
To determine if the region of mouse BIC that contains the
miR-155 precursor is sufﬁcient for expression of miR-155 in
mammalian cells, we inserted a 456 nt fragment from the third
exon of mouse BIC (BIC 99–554), including the miR-155
sequence, into the CS2+ expression vector (Figure 1A). The
BIC fragment is under the control of the simian CMV IE94
promoter (sCMV) and the SV40 late polyadenylation site is
present immediately afterwards. We assessed production of
mature miR-155 miRNA using a luciferase reporter construct
in which an artiﬁcial 22 nt sequence completely complemen-
tary to miR-155 was present in the 30-UTR after luciferase
(UAS-luc-miR155as, Figure 1B). Coexpression of miR-155
with the luc-miR-155as reporter should lead to cleavage of
the luciferase mRNA by RISC and a consequent reduction
in luciferase activity. Cotransfection of mouse P19 cells with
the UAS-luc-miR-155as reporter and BIC 99–554 reduced
luciferase activity more than 5-fold, relative to cotransfection
of the luciferase reporter with a control vector that did not
contain BIC sequences, indicating that expression of the
mouse BIC third exon fragment is sufﬁcient to produce mature
miR-155 (Figure 1C). To delimit the domain of BIC necessary
for miR-155 production, we constructed a series of vectors
with various deletions within the BIC 99–554 region and
tested their ability to inhibit the luciferase reporter in cotrans-
fection assays (Figure 1A and C). The smallest fully functional
domain tested contained 108 nt fragment (BIC 134–241). This
segment of BIC contains the miR-155 stem–loop precursor
and adjacent evolutionarily conserved sequences that can form
an extendedRNA duplex (35). Furtherdeletion from the 30 end
of this sequence (BIC 134–232 or BIC 99–232) substantially
decreased inhibition of the luciferase reporter, suggesting that
miR-155 production requires the extended RNA duplex adja-
cent to the precursor stem–loop, consistent with previous anal-
yses of miRNA primary transcript processing by Drosha
(18,46). BIC 134–416 and BIC 134–283 appeared slightly
more efﬁcient at reducing luciferase activity than the original
BIC 99–554. Expression of BIC 134–283 without the SV40
polyadenylation site (BIC 134–283 DpA) also efﬁciently
inhibited luciferase activity, suggesting that efﬁcient
polyadenylation is not necessary for miR-155 production. Pro-
duction of miR-155 was also conﬁrmed by northern blot ana-
lysis of RNA collected from transfected cells for a subset of
the BIC-derived vectors. A single band of the expected size
was detected by a probe complementary to miR-155 for all
vectors tested except BIC 134–232 (Figure 1D), consistent
with the limited inhibition of the UAS-luc-miR-155as reporter
by this vector. The BIC 134–283 DpA produced a higher level
of mature miR-155 than the other vectors.
We tested whether we could use a BIC-derived vector for
RNAi by replacing miR-155 with a synthetic miRNA
sequence complementary to a target mRNA. We constructed
a variant of the BIC 134–283 vector in which the miR-155
stem–loop precursor could be replaced by insertion of a syn-
thetic 64 nt DNA duplex that encoded a synthetic miRNA
(Figure 2). We refer to this synthetic variant of the
134–283 domain of BIC as the SIBR (synthetic inhibitory
BIC-derived RNA) cassette. We replaced the miR-155
sequence with either of two 22 nt sequences completely com-
plementary to the 30-UTR of the mouse neuroD1 mRNA
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the position of the ﬁrst nucleotide in the complementary target
sequence). The sequence of the complementary strand in the
stem–loop was altered to maintain the RNA duplex. The loop
sequence of the BIC/miR-155 precursor, as well as two
unpaired nucleotides in the miRNA precursor duplex, were
retained in these derivatives (Figure 2). These vectors were
expected to produce synthetic 22 nt miRNAs complementary
to the NeuroD1 mRNA in mammalian cells. We refer to these
synthetic short RNAs here as miRNAs, although they could be
considered siRNAs under the current terminology used for
RNAi in mammalian cells.
We assessed whether various SIBR vectors (Figure 3A) are
functionally effective as RNAi vectors for producing synthetic
miRNAs and inhibiting artiﬁcial target sequences. First, north-
ern blot analyses using a probe complementary to the intro-
duced miRNA sequences indicated that both the SIBR
ND1-1379 and SIBR ND1-1888 vectors produced a single
miRNA of the same size as miR-155 in transfected cells
(Figure 3B and data not shown). As we observed for
miR-155, removal of the SV40 polyadenylation site from
the SIBR ND1-1379 vector (Figure 3A: ND1-1379 DpA)
increased the level of the ND1-1379 miRNA (Figure 3B).
In a reporter assay, either of the SIBR ND1 vectors effectively
reduced luciferase activity when cotransfected with a reporter
construct that expressed an mRNA for the luciferase coding
region followed by the mouse NeuroD1 30-UTR (UAS-luc-
ND1-UTR) (Figure 3C). Activity of the reporter was not
reduced by cotransfection of the BIC 134–283 vector, indi-
cating that inhibition was dependent on the synthetic
NeuroD1-complementary miRNA sequences in the SIBR cas-
sette. A luciferase reporter that contained a sequence comple-
mentary to the second strand of the stem–loop in the
ND1-1379 SIBR cassette was inhibited <2-fold (data not
shown), indicating that the NeuroD1-complementary ﬁrst
strand is likely to preferentially accumulate in the cell as
the functional miRNA.
We tested whether two different miRNAs could be pro-
duced from a single transcription unit using the BIC-derived
sequences. The NeuroD1-1379 SIBR cassette and the BIC
134–283 fragment were inserted in tandem into the CS2+
vector (Figure 3A: SIBR ND1-1379 + BIC 134–283).
Figure 1. IdentificationoftheminimalregionofBICformiR-155expression.(A)SchematicrepresentationofthemouseBICnon-codingRNA,whichcontainsthe
miR-155 precursor in the third exon. To express miR-155, 455 nt of the BIC third exon was placed under the control of the sCMV RNA polymerase II promoter,
followed by the SV40 late polyadenylation site. Smaller fragments of the third exon (with boundaries based on homologous sequences among human, mouse, and
chick BIC RNAs), were used to determine the minimal domain within the third exon of BIC required for miR-155 expression. Positions of starting and ending
nucleotides are indicated. Exon and intron sizes are not to scale. (B) The UAS-luc-miR-155as reporter contains a single copy of a 22 nt artificial miR-155 target
sequence perfectly complementary to miR-155, inserted into the 30-UTR of the luciferase mRNA. (C) Relative luciferase activity after cotransfection of BIC
expression vectors with the UAS-luc-miR-155as reporter. CS2+MT, which expresses a multimerized myc-epitope tag, was used as a control. BIC 134–283 DpA
indicates the BIC 134–283 expression vector with the polyadenylation signal deleted. Standard errors are indicated. (D) Upper panel: northern blot for miR-155 in
cells transfected with the indicated vectors. The control vector is ND1-1379, in which the miR-155 sequence is replaced with an unrelated sequence (see Figure 2).
Lower panel: the same blot re-probed for the U6 snRNA as a loading control.
PAGE 5 OF 14 Nucleic Acids Research, 2006, Vol. 34, No. 7 e53Figure 2. RNAivectorsbasedonthemiR-155primarytranscriptBIC.TheSIBRcassettewasconstructedbyreplacingthemiR-155precursorstem–loopintheBIC
134–283 fragment with a polylinker (orange) containing inverted Bbs1 restriction sites. The Bbs1 cut sites (filled triangles) are outside the recognition sites
(underlined).Asynthetic64ntDNAduplexcanbeinsertedinwhichthemiR-155miRNAsequenceisreplacedbyasyntheticmiRNAsequence(blue).Theprimary
RNA transcript from the SIBR vector is indicatedabove the schematic, with the miRNA containing stem–loopindicatedand shown in more detail on the right. The
stem–loopintheprimaryRNAisprocessedbyDroshatoreleaseastem–looppre-miRNA,whichisthenprocessedbyDicertoreleasethematuremiRNA.Expected
Droshacleavagesitesareindicatedbyopentriangles.EachmaturemiRNAisunderlined.ThemiR-155sequenceinthestem–loopoftheBICRNA(red)isreplaced
by either of two synthetic miRNA sequences (blue or purple) perfectly complementary to the 30-UTR of the mouse NeuroD1 mRNA (ND1). The complementary
strandofthestem–loopsfortheND1miRNAswasalteredtomaintainapartialduplexwithtwosinglebasegaps(lowercase).Theloop(grey)andflankingsequences
(upper case black) are from BIC. Numbers for synthetic miRNAs indicate the first nucleotide of the target mRNA that is complementary to the miRNA.
Figure3.SequencespecificinhibitionbySIBRvectors.(A)SchematicdiagramsofvariantsofSIBRexpressionvectorswithsingleortandemcassettes.(B)miR-155
and the ND1-1379 synthetic miRNA are detected as single bands and at similar levels by northern blot analysis of RNA from P19 cells transfected with single and
tandemSIBRvectors.Deletionofthepolyadenylationsignal(ND1-1379DpA)increasedthelevelofND1-1379miRNA.Bottompanel:thesameblotre-probedfor
the U6 snRNA as a loading control. (C) Cotransfection of SIBR vectors expressing miRNAs complementary to NeuroD inhibit a cotransfected luciferase reporter
containingthemouseNeuroD130-UTR,whileBIC134–283hasnoeffectonluciferaseactivity.(D)AvectorwithbothaND1-1379SIBRcassetteandBIC134–283
intandemeffectivelyinhibitsaluciferasereporterforeithermiRNA.Thelevelofinhibitionfromthetandemvectoriscomparablewiththatoftheindividualvectors.
Standard errors are indicated.
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vector produced both the ND1-1379 miRNA and the miR-155
miRNA at levels similar to the individual vectors (Figure 3B,
right panel). Also, the SIBR ND1-1379 + BIC 134–283 vector
inhibited both the UAS-luc-miR-155as and UAS-luc-
ND1-UTR reporters in cotransfection assays (Figure 3D).
Inhibition by the tandem SIBR cassette vector in this assay
was as effective as inhibition by either the BIC 134–283 or
ND1-1379 SIBR vector. A control luciferase reporter that
lacked target sequences for both miR-155 and ND1-1379
was not inhibited by cotransfection of BIC 134–283, SIBR
ND1-1379 or SIBR ND1-1379 + BIC 134–283 (data not
shown).
Since the SIBR cassette can be expressed using a RNA
polymerase II transcript, we were interested in developing a
vector that could express both a protein (e.g. a visible or
selectable marker) and one or more SIBR cassettes from a
single transcription unit. Some endogenous miRNAs are
located in the introns of protein coding genes and at least
some of these intronic miRNAs are coexpressed with the cor-
responding mature mRNA, suggesting that an miRNA precur-
sor can be processedfrom an intron without preventing mRNA
accumulation (22). We constructed a derivative of the CS2
vector, US2, in which the simian CMV IE94 promoter was
replaced by the human ubC promoter and ﬁrst intron (43,47).
The US2 vector was modiﬁed to include the SIBR cassette
within the ubC intron, followed by an exon that encoded either
GFP or the puromycin resistance protein (designated UI2-
GFP-SIBR and UI2-puro-SIBR respectively) (Figure 4A).
We compared inhibition by the SIBR ND1-1888 cassette
expressed in each of these vectors, using the UAS-luc-
ND1-UTR reporter in cotransfection assays. For the CS2
and US2 vectors, a derivative that did not include a polyadeny-
lation site was used, since inhibition with these vectors was
more effective when the polyadenylation site was removed
(Figures 1 and 3; data not shown). All four vectors provided
comparable inhibition of the reporter (Figure 4B), indicating
that the SIBR cassette is effectively expressed when located
within the ubC intron. Expression of GFP was not appreciably
altered by the presence of the SIBR cassette in the UI2-GFP
intron (Figure 4C).
We have constructed SIBR vectors that target a variety of
different mRNAs (Table 1). Target sequences for miRNAs
were chosen using previously described rules for siRNA target
selection (48) and the additional constraint that the ﬁrst base of
the miRNA should be a U or an A. The miR-155 strand in the
mouse, human and chicken miR-155 stem–loop precursors is
two bases longer than its complementary strand, leading to the
presence of unpaired bases in the miRNA precursor duplex.
We have maintained the two base length difference between
the two strands in the synthetic constructs used here, and if
possible chose sequences that led to structures similar to the
native miR-155 precursors. For example, ND1-1888 has a
duplex similar to the mouse miR-155 precursor, ND1-380
has a duplex similar to the human miR-155 precursor, and
the Luc-1601 precursor has a duplex structure like the chicken
miR-155 precursor. However, some sequences preferentially
fold into alternate structures whentwo bases are removed from
the complementary strand, such that some effective SIBR
miRNA precursors have predicted duplex structures that differ
from all three miR-155 miRNA precursors (e.g. HP1g-664 and
c-Raf-2268). When compatible with the synthetic miRNA
sequence, we included GU base pairs between the miRNA
and its complement at the same positions that GU basepairs
are found in the miR-155 stem–loop precursor. However, the
GU base pairs are not essential for function (e.g. GAPDH-528
and Luc-1601 have none).
To determine the effectiveness of the SIBR vectors for
inhibiting endogenous mRNAs, we tested the ability of the
Figure 4. Expression of the SIBR cassette from an intron. (A) Schematic
diagrams of SIBR vectors: US2-SIBR DpA vector contains the SIBR cassette
in the second exon of human ubC gene, under control of the human ubC
promoter, but without a polyA signal. There is no coding region present in
either the CS2+SIBR DpA or US2-SIBR DpA vector. UI2 vectors also use the
humanubCpromoterbutcontaintheSIBRcassetteinthefirstintronoftheubC
gene,withtheGFPorpuromycin-resistanceproteinsexpressedfromthesecond
exon. SD and SA indicate splice donor and splice acceptor, respectively. Exon
and intron sizes not to scale. (B) Different SIBR vector designs expressing the
ND1-1888 miRNA against NeuroD1 were cotransfected with the NeuroD1
30-UTR luciferase reporter (see Figure 2). All four designs with ND1-1888
showed similar levels of inhibition of the reporter. Control SIBR vectors used
thesamedesignsbutexpressedanunrelatedmiRNAdirectedagainstthemouse
POSH mRNA. Standard errors are indicated. (C) Comparable GFP fluores-
cencewasdetected24haftertransfectionwithGFPexpressedfromubC-based
expressionvectors,whetherornotafunctionalSIBRcassettewaspresentinthe
ubC intron.
PAGE 7 OF 14 Nucleic Acids Research, 2006, Vol. 34, No. 7 e53ND1-1379 and ND1-1888 SIBR cassettes to reduce the level
of the NeuroD1 mRNA. P19 cells were cotransfected with a
UI2-puro-SIBR vector and a US2 expression vector for the
mouse neurogenin2 bHLH protein (Ngn2) to activate endoge-
nous NeuroD1 expression (40). Transiently transfected cells
were selected with puromycin to remove untransfected cells
(25). The level of NeuroD1 mRNA was measured by
qRT–PCR (Figure 5A). Both the ND1-1379 and the
ND1-1888 vectors reduced NeuroD1 mRNA levels about
5-fold, relative to a control SIBR vector directed against
luciferase, while ND1-380, a SIBR vector directed against a
sequence in the NeuroD1 coding region was more effective,
reducing the NeuroD1 mRNA by about 10-fold. The levels of
mRNAs from three unrelated genes, hypoxanthine ribosyl-
transferase (HPRT), glyceraldehyde-3-phosphate dehydroge-
nase (GAPDH) and the chromatin protein HP1g, were not
affected, indicating that inhibition of NeuroD1 by the SIBR
vectors was speciﬁc. We tested SIBR cassettes that target
additional endogenous genes using the UI2-GFP and UI2-puro
vectors, including HP1g, the tumor suppressor RASSF1 and
GAPDH. Vectors were tested in transiently transfected cells,
with puromycin selection after transfection. As controls for
non-speciﬁc effects, UI2-GFP and UI2-puro SIBR vectors
directed against luciferase were used. Both vectors that tar-
geted HP1g substantially reduced HP1g mRNA levels, in one
case nearly 30-fold (Figure 5B). The SIBR vectors directed
against RASSF1 were somewhat less effective, reducing
RASSF1 mRNA 3- to 5-fold (Figure 5B). Both vectors for
GAPDH reduced mRNA levels, with the more effective vector
reducing levels by about 10-fold (GAPDH-240, Figure 5C). In
all cases, the SIBR vectors did not decrease the expression of
non-targeted mRNAs (Figure 5A–C).
Previous studies have shown that the RISC complex cleaves
mRNAs between the target mRNA bases complementary to
the 10th and 11th nucleotides of a perfectly complementary
siRNA/miRNA (7,49). We used ligation-mediated RT–PCR to
identify the location of the 50 end of the 30 fragment from the
cleaved GAPDH mRNA in cells transfected with the
GAPDH-240 SIBR vector (9,50). All 12 clones sequenced
had the expected 50 end for the predicted cleavage product
(Figure 5D). This observation indicates that the SIBR vector
derived miRNAs function by RISC-mediated cleavage of the
target mRNA as expected and conﬁrms that the 50 end of the
synthetic miRNAisattheexpected position. Wealso observed
HP1g mRNA cleavage products with the expected 50 end in
RNA isolated from cells transfected with UI2-GFP-SIBR
HP1g-664 (data not shown).
One potential application of the UI2-GFP-SIBR vectors is
RNAi analysis using individual identiﬁed cells. We transiently
transfected cells with UI2-GFP-SIBR HP1g-664 or UI2-
GFP-SIBR luc-1601. Cells were ﬁxed and processed for
indirect immunoﬂuorescence to detect GFP and the endoge-
nous HP1g protein (Figure 6). UI2-GFP-SIBR HP1g-664
transfected cells that expressed GFP had low or undetectable
HP1g signals, while untransfected cells or the cells transfected
with the UI2-GFP-SIBR luc-1601 vector had strong HP1g
signals. For the cells transfected with the UI2-GFP-SIBR
luc-1601 control vector, 96% of the GFP positive cells
were strongly positive for HP1g (n ¼ 110 cells). For the
cells transfected with UI2-GFP-SIBR HP1g-664, only 4%
of the GFP positive cells were strongly positive for HP1g
(n ¼ 158 cells). These observations indicate that there is
efﬁcient coexpression of the synthetic miRNA and the GFP
marker at the single cell level.
We also compared the inhibitory efﬁciency of SIBR vector
with a previously described RNA polymerase III driven
shRNA vector for the same target mRNA. The U6-Tubb3HP2
vector (originally named U6-BT4HP2) expresses an effective
Figure 5. Knock-down of endogenous genes using UI2 SIBR vectors. (A) qRT–PCR measurements of mRNA levels in P19 cells transiently cotransfected with an
expression vector for Ngn2 (to activate endogenous NeuroD1 expression), and various UI2-puro-SIBR vectors. The level of NeuroD1 mRNA was reduced by
miRNAs directed against the NeuroD1 30-UTR (see Figure 2) or coding region (ND1-380), but not by a control miRNA directed against Luciferase. GAPDH and
HPRT mRNA levels were not reduced. (B) UI2-GFP-SIBR vectors expressing miRNAs that target the HP1g or RASSF1 mRNAs reduced the levels of the
corresponding endogenous mRNA in transfected P19 cells, but not the HPRT mRNA. (C) UI2-puro-SIBR vectors expressing miRNAs directed against GAPDH
reduce endogenous GAPDH mRNA levels. (D) Expression of the GAPDH-240 miRNA leads to cleavage of the endogenous GAPDH mRNA at the expected site
(see text). In A–D, transfected cells were selected with puromycin to remove untransfected cells. UI2-GFP-SIBR vectors in B were cotransfected with US2-puro to
permit selection.
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(Tubb3), under the control of the mouse U6 promoter
(24,51). We constructed a vector directed against mouse tubu-
lin b3 (UI2-GFP-SIBR Tubb3-1549) that targets a sequence
overlapping the target site of the U6-Tubb3HP2 shRNA vec-
tor. U6 or SIBR vectors were cotransfected with a reporter
construct that contains the 30-UTR of mouse tubulin b3
inserted after the luciferase coding region. In a luciferase
reporter assay, the UI2-GFP-SIBR vector reduced luciferase
activity as effectively as the U6 vector at three different plas-
mid amounts (Figure 7A). We also transiently cotransfected
P19 cells with U6 or UI2-GFP-SIBR vectors directed against
tubulin b3, or control SIBR vectors, and the US2-Ngn2 vector
to activate neuronal differentiation (40). An additional UI2-
GFP-SIBR vector which targets a different sequence in the
tubulin b33 0-UTR was also tested. After four days of differ-
entiation in culture, endogenous tubulin b3 expression was
detected by indirect immunoﬂuorescence. Most cells trans-
fected with U6-Tubb3HP2, UI2-GFP-SIBR Tubb3-1549 or
UI2-GFP-SIBR Tubb3-1512 vectors showed substantially
reduced or undetectable tubulin b3 protein expression in
cell bodies and neurites when compared with cells tranfected
with the control vectors (Figure 7B).
As described above, both miR-155 and a SIBR cassette can
be expressed from a single transcription unit. The CS2+SIBR
and UI2-SIBR vectors were designed to facilitate multimer-
izing the SIBR cassette by providing unique but compatible
restriction sites ﬂanking the cassette (Figure 8A and B). To
determine if a tandem SIBR vector can be used to inhibit two
endogenous mRNAs, we constructed SIBR vectors that spe-
ciﬁcally targeted the related kinases B-Raf and c-Raf. An
effective SIBR cassette against each kinase was inserted indi-
vidually or in tandem into the intron of the UI2-puro-SIBR
vector (Figure 8C). Transient transfection of SIBR vectors
against either c-Raf or B-Raf effectively and speciﬁcally
reduced the level of the targeted Raf protein, but not the
untargeted Raf kinase, while the tandem B-Raf + c-Raf
SIBR vector reduced the levels of both proteins
(Figure 8D). The level of the downstream kinase ERK,
which was not targeted, remained unchanged.
The ability to effectively express two synthetic miRNAs
from a single transcript raised the possibility that including
more than one copy of a miRNA against the same target
mRNA in a single SIBR vector might improve inhibition of
the target. We compared the UI2-GFP vector with two to eight
tandem SIBR cassettes, each containing the same miRNA
directed against luciferase, with UI2-GFP vector with a single
copy of the same SIBR cassette (Figure 9A). Inhibition of the
reporter increased with the number of SIBR cassettes, at three
different DNA concentrations, and the vector with eight copies
was the mosteffective (Figure 9B).The UI2-GFP-SIBR vector
containing a single copy of an effective miRNA against the
unrelated gene POSH (C. Figueroa, K.-H. Chung, J. Taylor,
M.Deo,E.J.Brace,A.W.Avery,D.L.TurnerandA.B.Vojtek,
manuscript submitted) was used as a control. A vector with
eight copies of the miRNA against POSH did not alter
luciferase expression relative to the control, indicating that
a multimerized SIBR cassette did not have a non-speciﬁc
effect on luciferase expression.
Serendipitously, we observed that expression of an intronic
SIBR cassette from a two intron expression vector enhanced
target inhibitionrelative tothe UI2-SIBR single intron vectors.
A vector was constructed in which the SIBR cassette is located
in an intron from the rabbit globin gene, inserted into a modi-
ﬁed UI2 vector after the existing ubC intron (UI4-GFP-SIBR
vector, Figure 9C). When tested in a cotransfection reporter
assay at three different DNA concentrations, the UI4-
GFP-SIBR luc-1601 vector showed consistently better inhibi-
tion of luciferase than the UI2-GFP-SIBR luc-1601 vector
(Figure 9D). Inhibition by the UI4-GFP SIBR luc-1601 vector
was approximately the same as the level of inhibition by a
UI2-GFP-SIBR luc-1601·2 vector that has two copies of the
luc-1601 SIBR cassette. Including two copies of the luc-1601
SIBR cassette in the UI4-GFP-SIBR vector increased inhibi-
tion relative to a single copy of the SIBR cassette, indicating
that multimerization of the SIBR cassette can be used to fur-
ther enhance inhibition with the UI4-GFP-SIBR vector
(Figure 9D). To test whether the enhanced inhibition was
speciﬁc to the expression of the SIBR cassette from the rabbit
globin intron, we constructed a single intron vector similar to
UI2-GFP-SIBR in which the ubC intron was replaced with the
rabbit globin intron/SIBR cassette (still driven by the ubC
promoter). That vector provided target inhibition similar to
UI2-GFP-SIBR (data not shown), suggesting that the
enhanced inhibition with UI4-GFP-SIBR is a result of having
two introns present in the transcript or expressing the SIBR
cassette from the second intron, rather than a function of the
speciﬁc intronic sequences that ﬂank the SIBR cassette.
DISCUSSION
Vector-based RNAi has become a popular approach for ana-
lyzing gene function in mammalian cells. We describe here a
new RNA polymerase II vector system for RNAi, the SIBR
vectors, based on BIC, the primary transcript for the miR-155
miRNA. The SIBR vectors produce a synthetic miRNA, per-
fectly complementary to a target mRNA, leading to target
mRNA cleavage. RNA polymerase II vectors based on pro-
duction of a synthetic miRNA from a modiﬁed miR-30
miRNA precursor, were ﬁrst described and characterized by
Cullen and colleagues (8,27,28). Optimized RNAi vector
designs based upon miR-30 have been described recently
and have been adapted for use in RNAi libraries (31,32,52).
Both the miR-155 based SIBR vectors and recent miR-30
Figure 6. Reduction of endogenous HP1g protein in single cells identified by
coexpressed GFP. P19 cells transfected with the UI2-GFP-SIBR HP1g-664
vector express GFP (green) and show reduced HP1g by indirect immunfluor-
escence (red) when compared with untransfected cells (no GFP). The HP1g
signal in cells transfected with the UI2-GFP-luc1601 control vector remains
unchanged.
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polymerase III shRNA vectors. However, in contrast to
previously described miR-30 based or shRNA vectors, we
show that the SIBR vectors can be used to express multiple
miRNA expression cassettes from a single transcript. Two
different synthetic miRNAs directed against two different
target mRNAs can be expressed from a single polycistronic
transcript containing two SIBR cassettes, and both miRNAs
provide effective RNAi. Alternately, multimerization of a sin-
gle miRNA cassette up to at least eight copies can be used to
increase the inhibition of a single target mRNA. We also ﬁnd
that expression of an intronic SIBR cassette from a two intron
vector enhances inhibition, and this design can be combined
with multimerization of the SIBR cassettes.
Although synthesis of multiple endogenous miRNAs
from polycistronic transcripts has been reported (16,20,21),
effective vectors for RNAi that can target more than one
mRNA using a single transcription unit have not been
described. Cullen and colleagues demonstrated coexpression
of a synthetic miRNA and the natural miR-30 miRNA from a
single transcript using an expression vector (53), but they did
not test whether two synthetic miRNAs could be used for
effective target inhibition by RNAi. Zhou et al. reported
that expressing two tandem copies of a miR-30-based
synthetic miRNA in a single transcription unit was less effec-
tive for RNAi than a single copy of the same miRNA (29).
That observation raised the possibility that the inclusion of
two or more miRNAs in a transcript might reduce the amount
of each mature miRNA produced: processing of one miRNA
could potentially destabilize the transcript or otherwise
interfere with the subsequent processing of other miRNAs
from the same transcript. Such problems would reduce the
utility of polycistronic vectors for RNAi. However, we
show that tandem expression cassettes for two different
miR-155-basedsyntheticmiRNAs can beexpressed in asingle
transcription unit, and each miRNA functions for RNAi with
an efﬁciency similar to that of a single miRNA expression
vector. We also found that the SIBR expression cassette for a
single miRNA could be multimerized in tandem, up to at
least eight copies, resulting in increased target inhibition.
The reason for the difference between the miR-30 and the
BIC/miR-155 based vectors in polycistronic transcripts is
not clear. Possibly tandem copies of the miR-30 derived
stem–loop folded into an unexpected structure; alternately,
BIC-derived sequences might stabilize a partially processed
pri-miRNA transcript or otherwise facilitate generation of pre-
miRNAs by Drosha.
An advantage of RNA polymerase II based RNAi vectors is
the ability to coexpress a synthetic miRNA and a protein
marker from a single transcription unit. Cullen and colleagues
demonstrated that a miRNA could be expressed from the
Figure 7. ComparableinhibitionbySIBRvectorsanda U6shRNAvector.(A)
A reporter assay comparing inhibition of a luciferase reporter containing 30-
UTR of mouse tubulin b3 (luc-Tubb3-UTR) cotransfected with either the UI2-
GFP-SIBR Tubb3-1549 vector or the U6-Tubb3HP2 vector. At three different
plasmid concentrations, both vectors showed comparable levels of inhibition.
Standard errors are indicated. (B) Reduction of endogenous mouse tubulin b3
proteinatasinglecellleveldemonstratedbyimmunocytochemistry.U6orUI2-
GFP-SIBR vectors were cotransfected into P19 cells together with the
US2-Ngn2vectortoinduceneuronaldifferentiationandb3tubulinexpression.
U6 transfections included the US2-GFP vector to label transfected cells. P19
cells transfected with a U6 shRNA vector or either of two UI2-GFP-SIBR
vectors (green) directed against b3 tubulin showed substantially reduced
tubulin b3 protein (red) by indirect immunfluorescence, relative to cells
transfected with control vectors.
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describe a vector of this design for RNAi (17). The miR-155
precursorstem–loopislocatedinan exon,butwe foundthat an
intronic SIBR cassette could be used to effectively express a
synthetic miRNA, while the mature mRNA from the same
transcription unit could encode a protein marker. Zhou
et al. described an RNAi vector in which a synthetic
miRNA derived from the miR-30-based precursor is expressed
from the intron of a protein marker gene under the control of
the human ubC promoter, using a vector design similar to our
UI2-GFP-SIBR vector (29). Additional RNAi vector designs
forcoexpressionofaproteinandanshRNArecentlyhavebeen
reported (54–56). We also observed that an intronic SIBR
cassette from the two intron UI4-GFP-SIBR vector increased
RNAi relative to the single intron UI2-GFP-SIBR vector.
The reason for the increased inhibition with the two intron
vector is unclear. Removal of the polyA signal from an
unspliced transcript with a SIBR cassette increased the
level of the mature miRNA and led to inhibition at a similar
level to a single intron vector. Possibly increased nuclear
retention of intronic and non-polyadenylated sequences (57)
facilitates processing of miRNA primary transcripts (19).
Several endogenous miRNA primary transcripts, including
the BIC RNA, have been reported to be retained in the nucleus
(17,58).
miR-155 is derived from the non-coding RNA BIC
(37,38,58). BIC was originally isolated based on its associa-
tion with lymphoma in chickens, and its minimal functional
domain contains the miR-155 precursor stem–loop (39). Our
data indicate that expression of a 108 nt fragment located
within the third exon of mouse BIC is sufﬁcient to produce
miR-155, consistent with the observation that the third exon of
human BIC is sufﬁcient for miR-155 expression (58). The
minimal fragment of BIC required for miR-155 expression
contains both the predicted miR-155 precursor and adjacent
ﬂanking sequences that form an extended RNA duplex (35).
Figure 8. Knock-downoftwoendogenousgenesusingasingleUI2SIBRvector.(A)SchematicoftheUI2-GFP/puro-SIBRvectorsshowinguniquerestrictionsites
flanking the SIBR cassette. Indicated in bold are restriction enzyme sites used for multiplexing SIBR cassettes. (B) Using appropriate restriction enzymes, it is
possible to create vectors with tandem SIBR cassettes rapidly. (C) Schematic of vectors with miRNAs directed against the B-Raf and/or c-Raf kinases, including a
vectorwithtandemB-Rafandc-RafSIBRcassettes.SchematicsinA-Carenottoscale.(D)WesternblotshowingreducedlevelsofeitherB-Raforc-Rafproteinin
cells transfected with SIBR vectors expressing a miRNA against the corresponding mRNA, but not in cells transfected with a control vector expressing a miRNA
directedagainstluciferase.ThevectorexpressingtwomiRNAstargetingtheB-Rafandc-RafmRNAsreducedthelevelsofbothRafproteins,butnottheERKkinase.
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essential for efﬁcient Drosha processing (46). The BIC
sequences we have used in the SIBR vectors are slightly larger
than the minimal domain required for miR-155 production,
extending an additional 42 nt on the 30 side. While not essen-
tial, expression of synthetic miRNAs was more consistent
among different vector designs when the 30 extension was
included (unpublished observations). The sequence of the 30
extension is highly conserved in mouse, human and chicken
BIC. Possibly, it contributes a structural feature that improves
Drosha recognition (59).
To produce synthetic miRNAs, we replaced both miR-155
and its complementary strand within the miR-155 precursor.
We retained the unmodiﬁed miR-155 loop between these
sequences, since the loop sequences are likely to be required
for efﬁcient nuclear export of the miRNA precursor (60). We
used standardsiRNA design rules, adjusted for the 22 nt length
of the miRNA, to select miRNA target sequences (48). When
possible, we incorporatedstructural features from the miR-155
precursor into the precursors for synthetic miRNAs. The
miRNA containing strand in the chicken, mouse and human
miR-155 precursors is 2 nt longer than its complementary
strand, although the precursors from each species accommo-
date the extra nucleotides with slightly different structures
(35). We removed two bases on the strand complementary
to the synthetic miRNA to create miRNA precursors with a
predicted structure similar to the miR-155 precursors. While
SIBR constructs in which the two strands are the same
length also function, they are less effective in some cases
(K.-H.Chung,datanotshown).Similarly,Zhouetal.observed
that synthetic derivatives of the miR-30 precursor that were
not completely duplexed increased RNAi relative to a perfect
duplex (29). It is not possible to maintain the miR-155-like
structure/basepairing for all synthetic precursor sequences, as
some sequences fold into alternate structures when two bases
are removed. We also included GU base pairs between the
synthetic miRNA and its complement at positions where GU
base pairs are found in the miR-155 precursor when possible.
SIBRvectors with several different predicted precursor duplex
structures and different numbers of GU basepairs were effec-
tive for RNAi, indicating that the precise duplex structure is
Figure 9. Increased inhibition by multiple SIBR cassettes expressed from a
single intron vector, and by use of a two intron vector. (A) Schematic repre-
sentation of UI2-GFP-SIBR vectors expressing one to eight tandem copies of
the same synthetic miRNA against luciferase. (B) P19 Cells transfected with a
fixedamountoftargetluciferasereporterandafixedtotalamountofDNAshow
dosedependentinhibitionofluciferase.AtthreedifferentDNAconcentrations,
an increased number of copies of the luc-1601 SIBR cassette in the UI2-GFP
vector provided better inhibition. The UI2-GFP-SIBR POSH-2852 control
vector expresses a functional synthetic miRNA directed against the mouse
POSH gene. A vector with eight copies of the POSH miRNA does not inhibit
luciferase. Total DNA amount was kept constant by replacing the SIBR vector
withtheUS2-MTvector,whichdoesnotexpressamiRNA.Standarderrorsare
indicated. (C) Schematics of the two intron UI4-GFP-SIBR vectors. UI4-GFP
vectors contain the SIBR cassettes in rabbit globin intron, inserted between the
exon 2 and GFP in exon 3. Exons 1 and 2 are noncoding. SD and SA indicate
splice donor and splice acceptor, respectively. Approximate intron size is
indicated. (D) Cotransfection reporter assay comparing the inhibition by
UI4-GFP-SIBR vectors to UI2-GFP-SIBR vectors expressing one or two
miRNAs against luciferase. At three different plasmid concentrations, the
UI4-GFP-SIBR vectors showed increased inhibition of luciferase relative to
the UI2-GFP-SIBR vectors. Standard errors are indicated.
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could have subtle effects on processing or other aspects of
miRNAproduction andsubsequent RNAi. Other aspects ofthe
miRNA precursor structure may also inﬂuence processing.
The 2 nt CA 30 overhang expected for the miR-155/SIBR
precursor is the optimal overhang sequence for Dicer process-
ing (61), which may contribute to the effectiveness of the
SIBR vectors.
Partial functional redundancy among related genes fre-
quently complicates functional analysis of individual genes.
We expect that the SIBR vectors will facilitate the analysis of
combinations of genes by RNAi. The vectors allow rapid
construction of designs expressing individual miRNAs, and
SIBR cassettes expressing single miRNAs can be readily
combined into tandem designs. Although the SIBR vectors
tested here expressed only two different miRNAs, vectors
with four or eight copies of the SIBR cassette provided
enhanced target inhibition, suggesting that SIBR vectors
directed against more than two targets are possible. In addi-
tion, synthesis of the miRNA(s) and a marker protein as a
single transcript facilitates the identiﬁcation or selection of
cells expressing the miRNA(s). Alternately, expression of a
biologically active protein could be combined with RNAi, e.g.
to allow functional analyses of a pathway downstream from
the active protein. Both the miRNA processing machinery and
RISC appear to be ubiquitous (3). We ﬁnd that the SIBR
vectors function effectively in a variety of mouse, rat and
human cell lines (K.-H. Chung, P. Patel and D.L. Turner,
unpublished data), and the vectors have been effective for
functional analyses of genes in primary mouse neural progeni-
tors and differentiating neurons (C. Figueroa, K.-H. Chung,
J. Taylor, M. Deo, E.J. Brace, A.W. Avery, D.L. Turner and
A.B. Vojtek, manuscript submitted). In addition to cell culture
studies, in vivo analyses of redundant gene function in iden-
tiﬁed cells should be feasible using SIBR vectors delivered by
electroporation (43).
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